JAK2 and acquired polycythemia vera: Initial studies have already produced interesting new insights by modelling the DNA-damaging inflammatory microenvironment using induced pluripotent stem cell-derived CD34+ progenitor-enriched cultures from a JAK2 V617F PV patient.